Compare American Well Corp (AMWL) vs JPMorgan Chase & Co (JPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Well Corp vs JPMorgan Chase & Co — how do they compare? American Well Corp trades at $9.89 (market cap $165.58M), while JPMorgan Chase & Co trades at $338.44 (market cap $901.58B). The key difference: JPMorgan Chase & Co is far larger — about 5445× American Well Corp's market cap, and JPMorgan Chase & Co pays a 1.78% dividend while American Well Corp pays none. Which is the better fit depends on your goals.
| AMWL | JPM | |
|---|---|---|
Market Cap | $165.58M | $901.58B |
Sector | Health | Financials |
52-Week High | $9.91 | $339.22 |
52-Week Low | $3.78 | $282.84 |
Enterprise Value | -$9.66M | — |
Volume | — | 10,479,943 |
Dividend Yield | — | 1.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
JPMorgan Chase (JPM) trades at $336.47, up 0.3% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $360.38. Recent earnings beat expectations in Q1 2026 with EPS of $5.94 versus $5.47 forecast, though Q4 2025 missed. Revenue grew to $181.85 billion in 2025, with a net income margin of 31.61% and ROE of 17.03%. The stock shows strong institutional interest amid positive media coverage on banking sector resilience.
Outlook remains positive given earnings momentum and high analyst buy ratings (51.67%), but risks include geopolitical tensions impacting oil markets and cybersecurity threats highlighted in recent news. Cash flow trends show significant financing activities offsetting negative operational flows, requiring monitoring of balance sheet leverage amid economic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →
